Mentor acquires Perouse
This article was originally published in Clinica
Executive Summary
Mentor is set to acquire the developer of the Perthese silicone gel breast implant Perouse Plastie (Bornel, France), in a bid to augment its presence in the surgical aesthetics market. The transaction, expected to close this month, will see Mentor acquire all the shares of Perouse for Euro42m ($57m), which includes the assumption of Euro3m in net debt.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.